相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single Diastereomers of the Clinical Anticancer ProTide Agents NUC-1031 and NUC-3373 Preferentially Target Cancer Stem Cells In Vitro
Magdalena Slusarczyk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Sona Vodenkova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Synthesis and biological evaluation of 5′-C-methyl nucleotide prodrugs for treating HCV infections
Madhuri Dasari et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Parallel reaction pathways and noncovalent intermediates in thymidylate synthase revealed by experimental and computational tools
Svetlana A. Kholodar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
442TiPA phase I first-in-human, dose-escalation and expansion study to evaluate the safety and tolerability of NUC-3373 in patients with locally advanced, unresectable or metastatic solid malignancies
S Blagden et al.
ANNALS OF ONCOLOGY (2018)
Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states
Dan Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs
Jadd Shelton et al.
CHEMICAL REVIEWS (2016)
The Golden Age of Transfer Hydrogenation
Dong Wang et al.
CHEMICAL REVIEWS (2015)
Hotspots in an Obligate Homodimeric Anticancer Target. Structural and Functional Effects of Interfacial Mutations in Human Thymidylate Synthase
Outi M. H. Salo-Ahen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Long-Lived Trifluoromethanide Anion: A Key Intermediate in Nucleophilic Trifluoromethylations
G. K. Surya Prakash et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Preparation of Both C5′ Epimers of 5′-C-Methyladenosine: Reagent Control Trumps Substrate Control
Cavan M. Bligh et al.
JOURNAL OF ORGANIC CHEMISTRY (2014)
Concerted versus Stepwise Mechanism in Thymidylate Synthase
Zahidul Islam et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2′-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes
Johan Vande Voorde et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Phosphoramidate ProTides of the Anticancer Agent FUDR Successfully Deliver the Preformed Bioactive Monophosphate in Cells and Confer Advantage over the Parent Nucleoside
Christopher McGuigan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase
Daniela Cardinale et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Identification of thymidylate synthase as a potential therapeutic target for lung cancer
K. Takezawa et al.
BRITISH JOURNAL OF CANCER (2010)
5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
Koh Miura et al.
Cancers (2010)
Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: a review
Georgios V. Koukourakis et al.
MOLECULES (2008)
Cooperative inhibition of human thymidylate synthase by mixtures of active site binding and allosteric inhibitors
Leslie L. Lovelace et al.
BIOCHEMISTRY (2007)
Vibrationally enhanced hydrogen tunneling in the Escherichia coli thymidylate synthase catalyzed reaction
N Agrawal et al.
BIOCHEMISTRY (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
GJ Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: Current status
D Papamichael
STEM CELLS (2000)
分享论文
